Literature DB >> 35086662

Genetic IL-6 Signaling Modifies Incident Coronary Artery Disease Risk in Chronic Kidney Disease.

Zhi Yu, Seyedeh M Zekavat, Michael C Honigberg, Pradeep Natarajan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35086662      PMCID: PMC8944139          DOI: 10.1016/j.jacc.2021.11.020

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   27.203


× No keyword cloud information.
  5 in total

1.  Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease.

Authors:  Paul M Ridker; Jean G MacFadyen; Robert J Glynn; Wolfgang Koenig; Peter Libby; Brendan M Everett; Martin Lefkowitz; Tom Thuren; Jan H Cornel
Journal:  J Am Coll Cardiol       Date:  2018-05-29       Impact factor: 24.094

Review 2.  Interleukin-6: designing specific therapeutics for a complex cytokine.

Authors:  Christoph Garbers; Sylvia Heink; Thomas Korn; Stefan Rose-John
Journal:  Nat Rev Drug Discov       Date:  2018-05-04       Impact factor: 84.694

3.  IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial.

Authors:  Paul M Ridker; Matt Devalaraja; Florian M M Baeres; Mads D M Engelmann; G Kees Hovingh; Milana Ivkovic; Larry Lo; Douglas Kling; Pablo Pergola; Dominic Raj; Peter Libby; Michael Davidson
Journal:  Lancet       Date:  2021-05-17       Impact factor: 79.321

4.  The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.

Authors:  Daniel I Swerdlow; Michael V Holmes; Karoline B Kuchenbaecker; Jorgen E L Engmann; Tina Shah; Reecha Sofat; Yiran Guo; Christina Chung; Anne Peasey; Roman Pfister; Simon P Mooijaart; Helen A Ireland; Maarten Leusink; Claudia Langenberg; Ka Wah Li; Jutta Palmen; Philip Howard; Jackie A Cooper; Fotios Drenos; John Hardy; Michael A Nalls; Yun Rose Li; Gordon Lowe; Marlene Stewart; Suzette J Bielinski; Julian Peto; Nicholas J Timpson; John Gallacher; Malcolm Dunlop; Richard Houlston; Ian Tomlinson; Ioanna Tzoulaki; Jian'an Luan; Jolanda M A Boer; Nita G Forouhi; N Charlotte Onland-Moret; Yvonne T van der Schouw; Renate B Schnabel; Jaroslav A Hubacek; Ruzena Kubinova; Migle Baceviciene; Abdonas Tamosiunas; Andrzej Pajak; Roman Topor-Madry; Sofia Malyutina; Damiano Baldassarre; Bengt Sennblad; Elena Tremoli; Ulf de Faire; Luigi Ferrucci; Stefania Bandenelli; Toshiko Tanaka; James F Meschia; Andrew Singleton; Gerjan Navis; Irene Mateo Leach; Stephan J L Bakker; Ron T Gansevoort; Ian Ford; Stephen E Epstein; Mary Susan Burnett; Joe M Devaney; J Wouter Jukema; Rudi G J Westendorp; Gert Jan de Borst; Yolanda van der Graaf; Pim A de Jong; Anke-Hilse Mailand-van der Zee; Olaf H Klungel; Anthonius de Boer; Pieter A Doevendans; Jeffrey W Stephens; Charles B Eaton; Jennifer G Robinson; JoAnn E Manson; F Gerry Fowkes; Timonthy M Frayling; Jackie F Price; Peter H Whincup; Richard W Morris; Debbie A Lawlor; George Davey Smith; Yoav Ben-Shlomo; Susan Redline; Leslie A Lange; Meena Kumari; Nick J Wareham; W M Monique Verschuren; Emelia J Benjamin; John C Whittaker; Anders Hamsten; Frank Dudbridge; J A Chris Delaney; Andrew Wong; Diana Kuh; Rebecca Hardy; Berta Almoguera Castillo; John J Connolly; Pim van der Harst; Eric J Brunner; Michael G Marmot; Christina L Wassel; Steve E Humphries; Philippa J Talmud; Mika Kivimaki; Folkert W Asselbergs; Mikhail Voevoda; Martin Bobak; Hynek Pikhart; James G Wilson; Hakon Hakonarson; Alex P Reiner; Brendan J Keating; Naveed Sattar; Aroon D Hingorani; Juan Pablo Casas
Journal:  Lancet       Date:  2012-03-14       Impact factor: 79.321

5.  Selective Interleukin-6 Trans-Signaling Blockade Is More Effective Than Panantagonism in Reperfused Myocardial Infarction.

Authors:  Marc Jonathan George; Nur Hayati Jasmin; Valerie Taylor Cummings; Angela Richard-Loendt; Francesca Launchbury; Kevin Woollard; Tabitha Turner-Stokes; Ana Isabel Garcia Diaz; Mark Lythgoe; Daniel James Stuckey; Aroon Dinesh Hingorani; Derek William Gilroy
Journal:  JACC Basic Transl Sci       Date:  2021-04-07
  5 in total
  1 in total

Review 1.  Targeting innate immunity-driven inflammation in CKD and cardiovascular disease.

Authors:  Thimoteus Speer; Stefanie Dimmeler; Stefan J Schunk; Danilo Fliser; Paul M Ridker
Journal:  Nat Rev Nephrol       Date:  2022-09-05       Impact factor: 42.439

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.